Jaejin An, PhD

Dr. Jaejin An is a pharmacoepidemiologist and outcomes researcher whose work focuses on understanding medication utilization, medication adherence, and disease management patterns. She also has interests in drug efficacy, safety, and pharmacoeconomics. Her research has applications for patient quality of care and outcomes.

Dr. An’s clinical focus is in the treatment, prevention, and comorbidity management of cardiovascular diseases, including hypertension, dyslipidemia, atrial fibrillation, and diabetes. She has substantial experience leading and collaborating on multisite observational studies. She is the multiple PI of the NIH -funded studies to determine the optimal blood pressure screening and treatment strategies in young adults, and to improve atherosclerotic cardiovascular disease risk prediction and lipid lowering treatment strategies.